OXOLIFE
Oxolife is a biotech startup focused in R&D of reproductive efficiency and infertility treatments Oxolife (was founded in January 2013 by an entrepreneurial and multidisciplinary team formed biochemists and clinical Pharmacologist, with more than 10 year of expertise in R&D and pharmaceutical market.
OXOLIFE
Industry:
Biotechnology Health Care Medical
Founded:
2013-01-01
Address:
San QuÃrico Safaja, Catalonia, Spain
Country:
Spain
Website Url:
http://www.oxolife.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
100 K EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Current Employees Featured
Investors List
BStartup
BStartup investment in Venture Round - OXOlife
Official Site Inspections
http://www.oxolife.com
- Host name: d1102.dinaserver.com
- IP address: 82.98.134.27
- Location: Spain
- Latitude: 40.4172
- Longitude: -3.684
- Timezone: Europe/Madrid
More informations about "OXOlife"
OXOlife - Crunchbase Company Profile & Funding
Oxolife is a biotechnology company in the clinical phase of development. Oxolife is a biotech startup focused in R&D of reproductive efficiency and infertility …See details»
About us - Oxolife
Oxolife’s innovation is a first-in-class oral drug for the treatment of infertile women, named OXO-001, that increases embryo implantation success and pregnancy rates. Currently, there is no specific drug commercially available for …See details»
Oxolife 2025 Company Profile: Valuation, Funding
Oxolife General Information Description. Operator of a biotecnology company intended to improve female fertility. The company's drug acts directly on the …See details»
OXOLIFE - LinkedIn
Oxolife is a biotechnology company dedicated to enhancing female fertility, with a focus on embryo implantation in women undergoing assisted reproductive technologies (ART).See details»
OXOLIFE - The Org
Oxolife is a biotech startup focused in R&D of reproductive efficiency and infertility treatments Oxolife (was founded in January 2013 by an entrepreneurial and multidisciplinary team formed …See details»
OXOlife - Funding, Financials, Valuation & Investors - Crunchbase
Oxolife is a biotechnology company in the clinical phase of development. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log In. ... How much funding has …See details»
OXOlife - Contacts, Employees, Board Members, Advisors & Alumni
Organization. OXOlife . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. ... OXOlife has 2 board members and …See details»
OXOLIFE Company Profile - Office Locations, Competitors ... - Craft
OXOLIFE is a biotechnology company focused on female fertility. It develops OXO-001, a treatment to support female fertility success through acting on peri and post implantatory …See details»
Oxolife - Products, Competitors, Financials, Employees, …
Oxolife is a biotechnology company that develops a non-hormonal oral treatment, OXO-001, targeting the endometrium to improve embryo implantation for women undergoing assisted …See details»
News - Oxolife
Resilience. Passion. Purpose. These are the forces that drive innovation forward—and today, we celebrate them.We are … [Read more...] about Agnes Arbat winner ...See details»
Oxolife raises €5 million in a funding round and joins the …
The biotech Oxolife –focused on the development of a new treatment to improve the female fertility rate– has moved its headquarters to the Barcelona Science Park. The company, which …See details»
Oxolife - Overview, News & Similar companies | ZoomInfo.com
Nov 13, 2023 Oxolife is a small-sized clinical-stage biotech company, founded in 2013 by Ignasi Canals and Agnès Arbat, focus and committed to female fertility improvement. Read More. …See details»
Genesis Biomed | Biotech company Oxolife raises 5 million euros …
Oxolife, created to develop a new treatment to improve female fertility rate, completed its first funding round by raising 5,000,000 euros in an investment led by Inveready Asset …See details»
Pipeline - Oxolife
Embryo implantation OXO-001: an innovative treatment that improves women’s fertility by enhancing embryo implantation We are currently developing OXO-001, a first-in-class non …See details»
Genesis Biomed | “We could hit a new milestone in the treatment …
Agnès Arbat and Ignasi Canals lead Oxolife, a startup that is developing OXO-001, a drug with the potential to treat female infertility as it increases the chances of embryo implantation a …See details»
A pill for infertility - OGP News
Jul 9, 2024 Recently, Oxolife presented highly promising new data at ESHRE from its proof-of-concept Phase 2 double-blinded, randomised controlled trial of OXO-001, in which it was …See details»
Oxolife Appoints International Fertility Experts to its Scientific ...
Barcelona, Spain – 13th November 2023, Oxolife, the specialist biotech focused on enhancing embryo implantation in women undergoing Assisted Reproductive Technology (ART) fertility …See details»
Oxolife Appoints International Fertility Experts to its Scientific ...
Nov 13, 2023 Oxolife is currently fundraising to accelerate the progress of OXO-001 through the clinic and is also exploring potential partnerships to bring the benefits of OXO-001 to patients …See details»
Body sat for 11 days after overdose death in 'first-of-its kind ...
1 day ago CBC has learned that staff at a celebrated B.C. complex-care housing complex didn't find the body of a 60-year-old resident until nearly 11 days after she overdosed in her room, …See details»
OXOART2, selected as one of the most exciting pieces of ... - Oxolife
Jul 8, 2024 The OXOLIFE exploratory subset study analysed 96 women aged up to 40 years old who underwent a single embryo transfer, 42 receiving placebo and 54 receiving a daily dose of …See details»